Attached files
| file | filename |
|---|---|
| EX-99.3 - PRESS RELEASE DATED AUGUST 14, 2020 - TPT GLOBAL TECH, INC. | tptw_ex993.htm |
| EX-99.2 - PRESS RELEASE DATED AUGUST 7, 2020 - TPT GLOBAL TECH, INC. | tptw_ex992.htm |
| EX-99.1 - PRESS RELEASE DATED AUGUST 5, 2020 - TPT GLOBAL TECH, INC. | tptw_ex991.htm |
| EX-10.1 - COVID-19 PARKING LOT TESTING LICENSE AGREEMENT - TPT GLOBAL TECH, INC. | tptw_ex101.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report: August 5, 2020
TPT Global Tech, Inc.
(Exact name of registrant as specified in its charter)
|
Florida
|
|
333-222094
|
|
81-3903357
|
|
(State
or other jurisdiction of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer Identification
Number)
|
501 West Broadway, Suite 800, San Diego, CA 92101
(Address of Principal Executive Offices) (Zip Code)
(619)301-4200
Registrant's telephone number, including area code
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ] Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
None
|
Title of each Class
|
Trading Symbol
|
Name of each exchange on which registered
|
|
N/A
|
N/A
|
N/A
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2 of this chapter)
Emerging Growth Company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the
Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement
On
August 13, 2020, TPT Global Tech, Inc. (“TPT”) entered
into a COVID-19 Parking Lot Testing License Agreement ("License
Agreement") with Wal-Mart Real Estate Business Trust and Wal-Mart
Stores East, LP ("Wal-Mart"). The License Agreement with Wal-Mart
allows TPT to start offering Drive Thru COVID-19 testing for up to
five Wal-Mart locations in Florida and up to five Wal-Mart
locations in California.
On
January 31, 2020, the United States Secretary of Health and Human
Services ("HHS") declared a public health emergency pursuant to
section 319 of the PHS Act, 42 U.S.C. 247d, for the entire United
States to aid in the nation's health care community response to the
COVID-19 outbreak. This License Agreement is TPT’s response
to the COVID-19 outbreak and an opportunity for TPT to assist with
this national emergency.
TPT
MedTech, a subsidiary of TPT Global Tech, Inc., will launch its
QuikLAB operations around Miami Dade County, Florida and San Diego,
California. The TPT QuikLAB will offer PCR and Antibody rapid tests
to its customers. Customers will also be able to download the newly
developed QuikLAB App. The QuikLAB App allows customers to schedule
testing appointments to help alleviate long lines. It also allows
customers to choose which QuikLAB location best fits their
availability and receive their rapid test results when completed.
The QuikLAB App also has a "Hall Pass" Certificate feature that
will allow employers, sport venues, nightclubs, restaurants and
schools to monitor individuals, and give businesses and communities
a sense of freedom and safety to allow entrance to said
venues.
A copy
of the COVID-19 Parking Lot Testing License Agreement is attached
hereto as Exhibit 10.1.
Item 7.01 Regulation FD Disclosure.
Press Release
The information in this Item 7.01 of this Current Report is
furnished pursuant to Item 7.01 and shall not be deemed "filed" for
any purpose, including for the purposes of Section 18 of the
Exchange Act, or otherwise subject to the liabilities of that
Section. The information in this Current Report on Form 8-K shall
not be deemed incorporated by reference into any filing under the
Securities Act or the Exchange Act regardless of any general
incorporation language in such filing.
On
August 5, 2020, the Company issued a press release entitled
“TPT Global Tech’s "QuikLAB and SaniQuik" Airs on CBS 8
Local News San Diego, CA
.” A copy of the press release is attached
hereto as Exhibit 99.1.
On
August 7, 2020, the Company issued a press release entitled
“CORRECTION: TPT Global Tech’s "QuikLAB and SaniQuik"
FDA Correction.” A copy of the press release is attached
hereto as Exhibit 99.2.
On August 14, 2020, the Company issued a press release entitled
“TPT Global Tech’s Subsidiary TPT MedTech Signs Parking
Lot Testing Licensing Agreement with Wal-Mart Real Estate to Start
“QuikLAB” Operations in Florida and California.”
A copy of the press release is attached hereto as Exhibit
99.3.
Item 9.01 Exhibits
The following exhibits are filed with this report on Form
8-K.
|
Exhibit
Number
|
Exhibit
|
|
COVID-19
Parking Lot Testing License Agreement
|
|
|
Press
Release dated August 5, 2020
|
|
|
Press
Release dated August 7, 2020
|
|
|
Press
Release dated August 14, 2020
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on
its behalf by the undersigned, hereunto duly
authorized.
TPT GLOBAL TECH, INC.
By:/s/ Stephen J. Thomas
III
Stephen
J. Thomas III,
Title:
Chief Executive Officer
Date:
August 14, 2020